1. Abemaciclib sensitizes HPV‐negative cervical cancer to chemotherapy via specifically suppressing CDK4/6‐Rb‐E2F and mTOR pathways. (10th June 2020) Authors: Liu, Yuan; Zhao, Runsheng; Fang, Shanshan; Li, Quan; Jin, Yiqiang; Liu, Bo Journal: Fundamental & clinical pharmacology Issue: Volume 35:Number 1(2021) Page Start: 156 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗